http://web.archive.org/web/20140519165345id_/http://www.dailymail.co.uk/news/article-2632083/More-10-000-toddlers-Medicaid-given-ADHD-drugs-despite-guidelines-shouldnt-administered-children-four.html

by @entity0 more than 10,000 @entity2 toddlers are being given drugs for @entity4 despite pediatric guidelines stating that it should n’t be administered to children aged younger than four years old			1
the @entity8 ( @entity8 ) report found that children aged 2 and 3 – particularly those covered by @entity12 - were especially prone to being prescribed medication such as @entity14 and @entity15			1
the @entity17 ' adhd guidelines do n’t make reference to diagnosis in children under four , because experts believe hyperactive and impulsive behavior are appropriate for toddlers			2
the @entity8 has found that more more than 10,000 children under four years of age are being given @entity4 drugs each year it is widely considered within the medical profession that adhd symptoms – such as issues with paying attention - begin after age six and should be present for more than six months for a diagnosis to be made			1
the @entity8 states in the report that it has serious concerns about the safety and effectiveness of adhd drugs being used on children at such a young age			2
‘ it ’s absolutely shocking , and it should n’t be happening , ’ @entity38 , a children ’s mental health consultant told the @entity40			0
‘ we obviously do n’t have our act together for little children			0
’ the report , which was presented on friday at the @entity46 in @entity47 , was based on @entity12 claims in @entity49 and claims by privately insured families nationwide kept by research firm @entity52			0
drugs like @entity14 and @entity15 can help calm hyperactivity , but carry risks for growth suppression , insomnia and hallucinations with no nationwide @entity12 data currently available , dr. @entity59 said @entity49 ’s rates of the disorder are very typical of the @entity2 as a whole			1
' if we applied @entity49 ’s rate to the number of toddlers on @entity12 nationwide , we would expect at least 10,000 of those to be on adhd medication , ' she said			0
drug - free alternatives , such as teaching parents and day care workers to provide more structured environments for children , are being ignored , she warned			1
' families of toddlers with behavioral problems are coming to the doctor ’s office for help , and the help they ’re getting too often is a prescription for a @entity82 controlled substance , which has not been established as safe for that young of a child , ' said @entity59			0
' it puts these children and their developing minds at risk , and their health is at risk			0
' @entity59 did n't have an explanation for why toddlers covered by @entity12 are being medicated for the disorder far more often than those covered by private insurance			0
drugs like @entity14 and @entity15 can help calm hyperactivity , but carry risks for growth suppression , insomnia and hallucinations			1
a nationwide @entity8 survey last year found that 11 percent of children ages 4 to 17 have been diagnosed with @entity4 and that about one in five boys are diagnosed during childhood .			2

the @entity8 has found that more more than 10,000 children under four years of age are being given @entity4 drugs
pediatrics guidelines do n't make reference to diagnosis under four , because experts believe hyperactive behavior is appropriate for toddlers
drug - free alternatives , such as teaching parents and day care workers to provide more structured environments for children , are being ignored
drugs like @entity14 and @entity15 carry risks for growth suppression , insomnia and hallucinations
the research found that the *majority* of the toddlers were receiving the drugs through the @entity12 program

@entity17:American Academy of Pediatrics
@entity2:United States
@entity15:Adderall
@entity14:Ritalin
@entity12:Medicaid
@entity4:ADHD
@entity38:Anita Zervigon-Hakes
@entity8:Centers for Disease Control and Prevention
@entity46:Georgia Mental Health Forum
@entity52:MarketScan
@entity82:Class II
@entity0:David Mccormack
@entity40:New York Times
@entity47:Atlanta
@entity59:Visser
@entity49:Georgia